改良肌酐指数与血液透析患者骨折风险:Q-Cohort研究
该研究包含横断面和前瞻性队列两部分:横断面研究在78例血液透析患者中验证改良肌酐指数与生物电阻抗测定的骨骼肌质量显著相关;前瞻性队列纳入3030例维持性血液透析患者随访4年,发现改良肌酐指数较低与骨折风险增加相关。
要点
- 改良肌酐指数与BIA测定的骨骼肌质量显著相关
- 较低改良肌酐指数与血液透析患者骨折风险增加相关
- 男女患者中均观察到改良肌酐指数与骨折风险的关联
核心结论
- 改良肌酐指数与BIA测定的骨骼肌质量相关,较低改良肌酐指数与男性和女性血液透析患者骨折风险增加相关。
研究设计与样本
- 横断面研究纳入78例血液透析患者,前瞻性纵向队列研究纳入3030例维持性血液透析患者并随访4年。
主要发现
- 横断面研究中改良肌酐指数与BIA测定的骨骼肌质量显著相关。
- 中位随访3.9年期间140例患者发生骨折。
- 以改良肌酐指数最高四分位组为参照,男性Q1和Q2的多变量校正HR分别为7.81(95%CI 2.63-23.26)和5.48(95%CI 2.08-14.40),趋势P<0.001。
- 女性Q1和Q2的多变量校正HR分别为4.44(95%CI 1.50-13.11)和2.33(95%CI 0.86-6.31),趋势P=0.007。
关键数值与推荐
- 采用Fine-Gray比例亚分布风险模型,以全因死亡为竞争风险。
- 按改良肌酐指数进行性别特异性四分位分组,以Q4为参照。
临床怎么用
- 改良肌酐指数可作为血液透析患者骨骼肌质量的简易估算指标,低值提示骨折风险增加,或有助于风险分层。
局限性
- 改良肌酐指数仅单次评估。
- 缺乏残余肾功能、骨折部位和骨折原因的数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hemodialysis patients are at increased risk for bone fracture and sarcopenia. There is close interplay between skeletal muscle and bone. However, it is still unclear whether lower skeletal muscle mass increases the risk for bone fracture. STUDY DESIGN: Cross-sectional study and prospective longitudinal cohort study. SETTING & PARTICIPANTS: An independent cohort of 78 hemodialysis patients in the cross-sectional study and 3,030 prevalent patients undergoing maintenance hemodialysis prospectively followed up for 4 years. PREDICTOR: Skeletal muscle mass measured by bioelectrical impedance analysis (BIA) and modified creatinine index, an estimate of skeletal muscle mass based on age, sex, Kt/V for urea, and serum creatinine level. OUTCOMES: Bone fracture at any site. RESULTS: In the cross-sectional study, modified creatinine index was significantly correlated with skeletal muscle mass measured by BIA. During a median follow-up of 3.9 years, 140 patients had bone fracture. When patients were divided into sex-specific quartiles based on modified creatinine index, risk for bone fracture estimated by a Fine-Gray proportional subdistribution hazards model with all-cause death as a competing risk was significantly higher in the lower modified creatinine index quartiles (Q1 and Q2) compared to the highest modified creatinine index quartile (Q4) as the reference value in both sexes (multivariable-adjusted HRs for men were 7.81 [95% CI, 2.63-23.26], 5.48 [95% CI, 2.08-14.40], 2.24 [95% CI, 0.72-7.00], and 1.00 [P for trend < 0.001], and for women were 4.44 [95% CI, 1.50-13.11], 2.33 [95% CI, 0.86-6.31], 1.96 [95% CI, 0.82-4.65], and 1.00 [P for trend = 0.007] for Q1, Q2, Q3, and Q4, respectively). LIMITATIONS: One-time assessment of modified creatinine index; no data for residual kidney function and fracture sites and causes. CONCLUSIONS: Modified creatinine index was correlated with skeletal muscle mass measured by BIA. Lower modified creatinine index was associated with increased risk for bone fracture in male and female hemodialysis patients.
引用
- Yamada S, Taniguchi M, Tokumoto M, et al. Modified Creatinine Index and the Risk of Bone Fracture in Patients Undergoing Hemodialysis: The Q-Cohort Study. Am J Kidney Dis. 2017. PMID: 28450093. doi:10.1053/j.ajkd.2017.01.052
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。